Levetiracetam in L-dopa-induced dyskinesia.

@article{Meco2005LevetiracetamIL,
  title={Levetiracetam in L-dopa-induced dyskinesia.},
  author={Giuseppe Meco and Edito Fabrizio and Antonio Epifanio and Giorgio Di Raimondo and Nicola Vanacore and Letterio Morgante},
  journal={Clinical neuropharmacology},
  year={2005},
  volume={28 2},
  pages={102-3}
}
Dyskinesia To the Editor: Levetiracetam is a novel antiepi-leptic drug used in the treatment of the partial crisis as an add-on to other antiepileptic drugs. Although the underlying mechanism of action of levetirace-tam is unknown, the metabolism of GABA appears to be involved. In particular , it may counteract neuronal hyper-synchronization of the firing patterns of neurons in the substantia nigra pars reticulata and internal globus pallidus. 1 Levetiracetam has also been used in the therapy… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Levetiracetam for managing neurologic and psychiatric disorders.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists • 2009
View 4 Excerpts
Highly Influenced

Mitochondrial DNA single deletion in a patient with postural tremor.

Movement disorders : official journal of the Movement Disorder Society • 2008

Reversible corneal edema associated with amantadine use: an unrecognized problem.

Movement disorders : official journal of the Movement Disorder Society • 2008

Successful treatment of Holmes tremor by levetiracetam.

Movement disorders : official journal of the Movement Disorder Society • 2008

Levetiracetam in tardive dyskinesia.

Clinical neuropharmacology • 2006
View 3 Excerpts

Similar Papers

Loading similar papers…